This independent medical education activity features an expert interview with Robert E. Coleman, MD, FRCP, and Stephen Jones, MD, covering important data from a recent publication focusing on the updated analysis of the Intergoup Exemestane Study (IES). View Webcast
This Webcast is available 4 November 2011 through 4 November 2012

This independent medical education activity features an expert interview with Javier Cortés, MD, PhD, and Christopher Twelves, MD, focusing on the recent manuscript covering the EMBRACE trial of eribulin versus treatment of physician’s choice in metastatic breast cancer (Cortes J, et al. Lancet. 2011 March 3 [Epub ahead of print]).View Webcast
This Webcast is available 14 March 2011 through 14 March 2012

Expert perspectives with Fabrice André, MD, PhD, and Sunil Verma, MD, MSEd, FRCPC, regarding the phase I study of everolimus plus weekly paclitaxel and trastuzumab in patients with metastatic breast cancer pretreated with trastuzumab.
This Webcast is available from January 2011 to January 2012.

Expert perspectives with Matti Aapro, MD; Gary H. Lyman, MD, MPH, FRCP (Edin); and Ruth Pettengell, MD.

This independent medical education activity features an expert roundtable discussion with Matti Aapro, MD; Gary Lyman, MD, MPH, FRCP(Edin); and Ruth Pettengell, MD, and includes a downloadable reference slide deck.

This Webcast is available from 21 December 2010 to 21 December 2011.

Expert perspectives with Gregory Cheng, MD, PhD, and Aristoteles Giagounidis, MD, PhD, regarding the use of eltrombopag for the management of chronic immune thrombocytopenia.
This Webcast is available from 23 February 2011 to 23 February 2012.

Expert perspectives with Michele Baccarani, MD, and Jorge Cortes, MD, regarding the use of nilotinib in patients with chronic phase chronic myelogenous leukemia following imatinib resistance or intolerance.
This Webcast is available from 12 January 2011 to 12 January 2012.

Expert perspectives with Irene Ghobrial, MD, and Aristoteles Giagounidis, MD, PhD, regarding the use of everolimus for the management of relapsed or refractory Waldenström macroglobulinemia.
This Webcast is available from 11 January 2011 to 11 January 2012.

Expert perspectives with Anders Österborg, MD, PhD, and Aristoteles Giagounidis, MD, PhD, regarding ofatumumab as single-agent CD20 immunotherapy in fludarabine-refractory chronic lymphocytic leukemia
This Webcast is available from 17 September 2010 to 17 September 2011.

Expert perspectives with Neil Shah, MD, PhD, and Michael Deininger, MD, PhD, regarding dasatinib 100 mg once daily as second-line therapy in chronic-phase chronic myeloid leukemia
This Webcast is available from 7 September 2010 to 7 September 2011.

Expert perspectives with Thomas E. Hutson, DO, PharmD, FACP, and Lee Lokey, MD, regarding the use of targeted agents for the management of advanced renal cell carcinoma.

This Webcast is available from February 2011 to February 2012.

This independent medical education activity features an expert discussion between Jedd D. Wolchok, MD, PhD, and Axel Hauschild, MD, on the use of ipilimumab in the management of metastatic melanoma. View Webcast
This Webcast is available from January 2012 to January 2012.

This CME-certified activity features an expert discussion between Richard Riedel, MD, and David D’Adamo, MD, PhD, focusing on a recently published supplement to Seminars in Oncology covering the integration of novel treatments into the management of sarcoma. (D’Adamo D, et al. Semin Oncol. 2011;38(5Suppl3):S1-S42.)

This Webcast is available from 15 November 2011 to 15 November 2012.

This independent medical education activity features an expert interview with Giuseppe Saglio, MD, and Juan Luis Steegmann, MD, PhD, focusing on observations from an important publication reporting on the 24-month follow-up of the phase III randomized ENESTnd trial comparing nilotinib and imatinib for the treatment of patients with newly diagnosed chronic-phase chronic myeloid leukemia (CML). (Kantarjian HM, et al. Lancet Oncol. 2011;12(9):841-851)

This Webcast is available from 6 December 2011 to 6 December 2012.

This independent medical education activity features an expert interview with Elias Jabbour, MD, and Jane Apperley, MD, focusing on important data from a recent publication assessing the correlation of an early complete cytogenetic response (CCyR) and survival in patient with early chronic phase chronic myeloid leukemia (CML-CP) treated with tyrosine kinase inhibitors.

This Webcast is available from 2 December 2011 to 2 December 2012.